Rare diseases with temporomandibular joint manifestations: a systematic review
Mayank Shrivastava , Gabriel Tian , Liang Ye
Rare Disease and Orphan Drugs Journal ›› 2023, Vol. 2 ›› Issue (4) : 24
Rare diseases with temporomandibular joint manifestations: a systematic review
Background: Rare diseases (RDs) are serious often chronic progressive diseases that affect a smaller number of individuals. RDs can manifest in any region of the body and have systemic effects that are detrimental to individual health. Although RDs are individually rare, there are various debilitating disorders arising from RDs. One of the disorders that have been shown to have a negative impact on the health of RD patients is temporomandibular disorders (TMD). There is a dearth of data on the rare diseases and potential manifestations of TMD. The objective of this systematic review is to provide an overview of rare diseases and temporomandibular joint (TMJ) manifestations.
Method: The criterion for analysis of a rare disease and temporomandibular manifestations was inclusion in the Orphanet Classification of Rare Diseases and/or the National Organization for Rare Disorders (NORD)/The Genetic and Rare Diseases (GARD) databases. Only rare diseases with TMJ manifestations were recorded.
Results: A total of 54 RDs with TMJ manifestations and different TMD diagnoses were recorded. There were thirty-five studies derived from the Pubmed search, and the Orphanet input had 19 results. Overall, 13 different types of TMJ manifestations and TMD diagnoses were recorded in rare diseases.
Conclusion: TMJ manifestations associated with rare diseases are not uncommon. Healthcare professionals can play an important role in diagnosing and managing the complexity of RDs with TMJ manifestations. A multidisciplinary approach to TMD patients with rare diseases is advisable.
Rare diseases / temporomandibular joint / diagnosis / symptoms
| [1] |
National Organization for Rare Disorders (NORD). Available from: https://www.nidcd.nih.gov/directory/national-organization-rare-disorders-nord [Last accessed on 16 Nov 2023] |
| [2] |
Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex:32000R0141 [Last accessed on 16 Nov 2023] |
| [3] |
Federal Ministry of Health. Available from: http://www.bmg.bund.de/praevention/seltene-erkrankungen.html [Last accessed on 16 Nov 2023] |
| [4] |
|
| [5] |
|
| [6] |
National plan of action for people with rare diseases. Action fields, recommendations, proposed actions. Available from: https://www.namse.de/fileadmin/user_upload/downloads/National_Plan_of_Action.pdf [Last accessed on 16 Nov 2023] |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
List of rare diseases and synonyms in alphabetical order. Available from: https://www.orpha.net/orphacom/cahiers/docs/GB/List_of_rare_diseases_in_alphabetical_order.pdf [Last accessed on 16 Nov 2023] |
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
da Costa D, De-Carli AD, Probst LF, Grande AJ, Guerrero ATG. Oral manifestations in chikungunya patients: a systematic review.PLoS Negl Trop Dis2021;15:e0009401 PMCID:PMC8191910 |
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
Scarpa, M. Mucopolysaccharidosis type II. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993-2023. |
| [58] |
|
| [59] |
Akram A, Mohamad N, Salam A, Abdullah D, Zamzam R. Perception of final year dental students on pattern of medication for pulpitis.Dentistry2012;3:159 |
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
Costa TMP, Nascimento MDCC, Peralta-Mamani M, Rubira-Bullen IRF, Junqueira JLC, Soares MQS. Prevalence of orofacial alterations in patients with sickle-cell disease: systematic review and meta-analysis.Oral Surg Oral Med Oral Pathol Oral Radiol2023;135:642-60 |
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
/
| 〈 |
|
〉 |